AI assistant
STAAR SURGICAL CO — Director's Dealing 2022
Jul 6, 2022
31996_dirs_2022-07-05_07a6903b-9fe2-459c-aef5-8e3540ef2610.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-03-16
Reporting Person: Studholme Robert (Senior VP,Operations)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20850 | Direct |
| Common Stock | 502 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Options | $74.8 | 2032-03-07 | Commmon Stock (12547) | Direct | |
| Common Stock Options | $90.38 | 2031-03-12 | Common Stock (4879) | Direct | |
| Common Stock Options | $27.53 | 2030-03-20 | Common Stock (14629) | Direct | |
| Common Stock Options | $35.98 | 2029-03-14 | Common Stock (24284) | Direct | |
| Common Stock Options | $29.8 | 2028-06-14 | Common Stock (2368) | Direct | |
| Common Stock Options | $16.15 | 2028-03-14 | Common Stock (10015) | Direct | |
| Common Stock Options | $9.3 | 2027-03-21 | Common Stock (10000) | Direct | |
| Common Stock Options | $7.36 | 2026-04-04 | Common Stock (10000) | Direct |
Footnotes
F1: Of these, 9,917 are restricted shares subject to forfeiture rights, of which 2,010 will vest on 03/07/2023, 769 will vest on 03/12/2023, 2,346 will vest on 03/20/2023, 2,011 will vest on 03/07/2024, 770 will vest on 03/12/2024, and 2,011 will vest on 03/07/2025.
F2: The options become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025.
F3: The options become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.
F4: The options become exercisable as follows: 1/3 on 3/20/2021, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.
F5: All options became exercisable on or before the stated date.